- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 58.77M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $926.09M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $753.08M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $17.35M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $10.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $780.28M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $765.25M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $538.2M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $472.71M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.62B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.38B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.19B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $973.87M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.4B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.18B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 64.89M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $33.32M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $14.63M |
| Capex | Q1 2025 · Mar 31, 2024 | $7.28M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$109.52M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.35 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.36 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $201.01M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $16.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | $87.76M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $121.38M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $342.35M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $365.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $707.55M |